Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000726504 | SCV000345098 | uncertain significance | not provided | 2016-08-18 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000726504 | SCV000536529 | uncertain significance | not provided | 2017-01-24 | criteria provided, single submitter | clinical testing | A variant of uncertain significance has been identified in the COL6A1 gene. The P259L variant has not been published as a pathogenic variant, nor has it been reported as a benign variant to our knowledge. The P259L variant is not observed at a significant frequency in large population cohorts (Lek et al., 2016; 1000 Genomes Consortium et al., 2015; Exome Variant Server). The P259L variant is a semi-conservative amino acid substitution, which may impact secondary protein structure as these residues differ in some properties. This substitution occurs at a position that is conserved in mammals and in silico analysis predicts this variant is probably damaging to the protein structure/function. Based on the currently available information, it is unclear whether this variant is a pathogenic variant or a rare benign variant. |
Labcorp Genetics |
RCV003517178 | SCV004369328 | benign | Bethlem myopathy 1A | 2024-04-03 | criteria provided, single submitter | clinical testing |